The Patent Finder

Terms ending in 2031

Optinose Inc.

Every in-force patent on Optinose Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,038,630Delivery Devices
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 10,252,010Nasal Delivery Devices
In force
 · Medium confidence
OptiNose Inc.In forceMedium confidence
US 12,083,270Delivery Device and Method
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 8,910,629Delivery of Gases to the Nasal Airway
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 9,010,325Nasal Delivery Devices
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 11,291,626Nasal Delivery of Oxytocin
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 9,067,034Nasal Delivery Devices
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited